Third Party, Author at NFCR

Cancer Drug Design Company Associated with Longtime NFCR Support Attracts New Investment

Rasio Therapeutics, a company whose cancer drug research technology was developed and applied in part with funding provided over many years by the National Foundation for Cancer Research to University of Maryland, Baltimore, researcher Curt Civin, has raised additional investment funding....

Read more

NFCR CMO Brian Leyland-Jones Featured in Pancreatic Cancer Risk Overview

Insights from National Foundation for Cancer Research Chief Medical Officer Brian Leyland-Jones, along with such other authoritative sources as Johns Hopkins Medicine, the Mayo Clinic and the U.S. National Cancer Institute, are featured in this Eat This, Not That! overview of pancreatic cancer warning signs....

Read more

Interview with NFCR CEO Sujuan Ba Featured in BioBuzz—a Popular Regional Industry News Source

5 Questions With…” is a weekly BioBuzz series where interesting people share a little about themselves, their work and maybe something completely unrelated. This week the series features Dr. Sujuan Ba, president and chief executive officer of the National Foundation for Cancer Research....

Read more